Home

MOHAMMAD AZAB

CIK 1309653 · Chief Medical Officer · last filed 2026-01-13

MOHAMMAD AZAB is a Chief Medical Officer who has filed 42 SEC Form 4 insider transactions across 5 companies since 2009. The most recent filing, for LSTA, was dated Jan 13, 2026. Across all open-market trades the lifetime net is +$104.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $4.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.94M

Companies

5

Total Filings

42

Lifetime Open-Market Net

$104.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LSTA Director 104,925 $1.16 $121.7K $0 5 2026-01-13
DURECT CORP (DRRX) Delisted Director 0 $1.91 $0 $23.8K 8 2025-09-12
XENE Director 74,225 $64.94 $4.82M $80.9K 23 2023-12-20
ASTX Chief Medical Officer — $10.14 — $0 2 2012-12-10
Astex Pharmaceuticals, Inc (SUPG) Delisted Chief Medical Officer — — — $0 3 2011-03-28

Recent Filings

42 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-01-13 LSTA Grant (A) +30,456 $0 EDGAR
2025-09-12 DURECT CORP (DRRX) Delisted Mixed −6,000 $0 EDGAR
2025-01-13 LSTA Grant (A) +15,789 $0 EDGAR
2024-09-27 DURECT CORP (DRRX) Delisted Grant (A) — $0 EDGAR
2024-01-11 LSTA Grant (A) +19,480 $0 EDGAR
2023-12-20 XENE Exer (M) +4,320 $42.6K EDGAR
2023-06-23 DURECT CORP (DRRX) Delisted Grant (A) — $0 EDGAR
2023-06-02 XENE Grant (A) — $0 EDGAR
2023-01-11 LSTA Grant (A) +20,000 $0 EDGAR
2022-12-13 XENE Exer (M) +3,086 $8.3K EDGAR
Showing 1–10 of 42
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.